Drug Discovery Summit 2016
Loews Philadelphia Hotel *PHILADELPHIA, USA Visit the Venue to read more
We invite you to attend the Modern Drug Discovery & Development Summit (M3D), which will take place September 9-11, 2015 in Philadelphia, PA. The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research and current developments in the field.
The Summit will feature six conferences that will cover the latest hot topics in drug discovery:
A summit pass will get you access to all six conferences, or you can register for a two-day pass to attend either the first or second half of the Summit.
We hope to see you there!
The 2015 Advisory Committee
Dale G. Ando
Vice President, Therapeutic Development
& Chief Medical Officer
Charles R. Bridges
Professor & Chairman, Cardiovascular Surgery
Sanger Heart & Vascular Institute
Office of Cellular Tissue & Gene Therapies
Center for Biologics Evaluation & Research
US Food and Drug Administration (FDA)
Head of Research and Early Development, Rare Diseases Division
Principal & Chief Executive Officer
Cote Orphan Consulting
The Center for Gene Therapy
Nationwide Children's Hospital
Ohio State University College of Medicine
Erin A. Kimbrel
Director, Translational Research
Chief Science Officer
Equity Research Analyst
President & Principal Consultant
PDCI Market Access
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Loews Philadelphia Hotel
1200 Market St
Philadelphia, PA 19107
Discounted Group Rates: $169 per night
Discount Deadline: August 9, 2015
Toll Free Reservations: 1-888-575-6397
Mention GTCbio to receive the group rate.
Please note that submitting your abstract does NOT guarantee you a poster board at the meeting. GTCbio reserves poster boards based on the number of delegates whose abstracts have been approved and have registered and paid in full for the conference. Any abstracts submitted after the registration deadline will not be guaranteed a poster board.
You will be notified by the conference organizers via email as soon as your submission has been reviewed.
Posters accepted by the deadline will be considered for oral presentation one month prior to the conference.
Posters submitted after the deadline will be considered for poster presentation only.
Oral presentation winners will be notified via email or telephone 2-3 weeks before the conference.
Selected oral presenters will be posted on the agenda.
You must be registered for the conference to present at the poster session.
Conference program posters must be relevant to the main conference topics.
POSTER SIZE AND SET UP:
Poster boards are 4 feet in width by 6 feet in height. (122 cm by 182 cm). Posters should be portrait orientation, with maximum dimensions to fit on the board accordingly. If accepted for the poster session, an email will be sent with details on when and where to pin your poster. Pins will be provided.
For more information on customized packages, multi-conference sponsorship packages and networking opportunities, please contact:
Amber Kempf at 626-256-6405 x110 or amber.kempf [at] gtcbio.com
For more information on Media Relations, please contact:
Jennifer Chu at 626-256-6405 x105 or jennifer.chu [at] gtcbio.com